CXCL5 and cancer: We further elucidated that high PD-L1 expression in cancer cells resulted from enhanced phosphorylation of the Paxillin (PXN)/AKT signaling pathway triggered by CXCL5 stimulation of CXCR2 in a dose-dependent manner.